Transporter-mediated Bioavailability
Transporter-Mediated Bioavailability is a pharmacokinetic determinant that quantifies the extent and rate at which a drug, subject to active transport by membrane transporters, reaches systemic circulation in a functionally available form, thereby distinguishing it from passive diffusion-driven bioavailability.
5
Publications
272
Citations
30
Authors
20
Institutions
Publications per year
2017–2026
2
5
1–5 of 5
30
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 30
20
Peking University Third Hospital
Beijing, China
1 h-index
1 publications
17 citations
Beijing Children’s Hospital
Beijing, China
1 h-index
5 publications
85 citations
Université Paris Cité
Paris, France
1 h-index
2 publications
24 citations

Centre National de la Recherche Scientifique
Paris, France
1 h-index
2 publications
24 citations

University of Helsinki
Helsinki, Finland
1 h-index
4 publications
48 citations

Peking University
Beijing, China
1 h-index
1 publications
17 citations
Inserm
Paris, France
1 h-index
2 publications
24 citations

Délégation Paris 5
Paris, France
1 h-index
2 publications
24 citations
1–8 of 20
1 publications · 82 citations
1
h-index
1 publications · 66 citations
1
h-index
1 publications · 12 citations
1
h-index
1 publications · 17 citations
1
h-index
CPT · 1 publications · 95 citations
1
h-index
1–5